Bedaquiline-a Potential Inhibitor of COVID-19 Main Protease Based on Molecular Docking. Int. J. of Res. in Pharmacology &Pharmacotherapeutics 2021, 9 (2), 136-144. https://doi.org/10.61096/ijrpp.v9.iss2.2020.136-144.